Latest Saturn V Capital Management LLC Stock Portfolio
$552Million– No. of Holdings #21
Saturn V Capital Management LLC Performance:
2026 Q1: 8.66%YTD: 8.66%2025: 79.96%
Performance for 2026 Q1 is 8.66%, and YTD is 8.66%, and 2025 is 79.96%.
About Saturn V Capital Management LLC and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Saturn V Capital Management LP reported an equity portfolio of $552.2 Millions as of 31 Mar, 2026.
The top stock holdings of Saturn V Capital Management LP are , AMLX, . The fund has invested 12.8% of it's portfolio in ALUMIS INC and 10.9% of portfolio in AMYLYX PHARMACEUTICALS INC.
The fund managers got completely rid off OCULAR THERAPEUTIX INC (OCUL), CENTESSA PHARMACEUTICALS PLC (CNTA) and INVENTIVA SA (IVA) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), DYNE THERAPEUTICS INC (DYN) and JAZZ PHARMACEUTICALS PLC (JAZZ). Saturn V Capital Management LP opened new stock positions in CANDEL THERAPEUTICS INC (CADL) and ZURA BIO LTD. The fund showed a lot of confidence in some stocks as they added substantially to OVID THERAPEUTICS INC (OVID), DISC MEDICINE INC and INVIVYD INC (ADGI).
The top stock holdings of Saturn V Capital Management LP are , AMLX, . The fund has invested 12.8% of it's portfolio in ALUMIS INC and 10.9% of portfolio in AMYLYX PHARMACEUTICALS INC.
The fund managers got completely rid off OCULAR THERAPEUTIX INC (OCUL), CENTESSA PHARMACEUTICALS PLC (CNTA) and INVENTIVA SA (IVA) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), DYNE THERAPEUTICS INC (DYN) and JAZZ PHARMACEUTICALS PLC (JAZZ). Saturn V Capital Management LP opened new stock positions in CANDEL THERAPEUTICS INC (CADL) and ZURA BIO LTD. The fund showed a lot of confidence in some stocks as they added substantially to OVID THERAPEUTICS INC (OVID), DISC MEDICINE INC and INVIVYD INC (ADGI).
Saturn V Capital Management LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
Saturn V Capital Management LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Saturn V Capital Management LP made a return of 8.66% in the last quarter. In trailing 12 months, it's portfolio return was 133.49%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| candel therapeutics inc | 14,193,300 |
| zura bio ltd | 4,402,760 |
| alto neuroscience inc | 2,000,700 |
| satellos bioscience inc | 1,970,500 |
New stocks bought by Saturn V Capital Management LLC
Additions
| Ticker | % Inc. |
|---|---|
| ovid therapeutics inc | 66.67 |
| disc medicine inc | 50.76 |
| invivyd inc | 41.55 |
| immix biopharma inc | 23.15 |
| x4 pharmaceuticals inc | 11.31 |
| monopar therapeutics inc | 6.12 |
| pharvaris n v | 5.38 |
| vaxcyte inc | 3.2 |
Additions to existing portfolio by Saturn V Capital Management LLC
Reductions
| Ticker | % Reduced |
|---|---|
| cogent biosciences inc | -48.51 |
| dyne therapeutics inc | -45.96 |
| jazz pharmaceuticals plc | -34.31 |
| abivax sa | -16.4 |
| celcuity inc | -11.1 |
| amylyx pharmaceuticals inc | -3.26 |
Saturn V Capital Management LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| ocular therapeutix inc | -18,269,200 |
| inventiva sa | -1,316,720 |
| centessa pharmaceuticals plc | -7,070,130 |
Saturn V Capital Management LLC got rid off the above stocks
Sector Distribution
Saturn V Capital Management LP has about 58.3% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 58.3 |
| Others | 39.1 |
| 2.6 |
Market Cap. Distribution
Saturn V Capital Management LP has about 5.6% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
- MICRO-CAP
- LARGE-CAP
| Category | % |
|---|---|
| UNALLOCATED | 39.1 |
| MID-CAP | 22 |
| SMALL-CAP | 19.5 |
| MICRO-CAP | 13.8 |
| LARGE-CAP | 5.6 |
Stocks belong to which Index?
About 39.5% of the stocks held by Saturn V Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 60.5 |
| RUSSELL 2000 | 39.5 |
Saturn V Capital Management LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Saturn V Capital Management LLC
Saturn V Capital Management LP has 21 stocks in it's portfolio. About 77% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Saturn V Capital Management LP last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADGI | invivyd inc | 2.58 | 10,949,100 | 14,233,800 | added | 41.55 | ||
| AMLX | amylyx pharmaceuticals inc | 10.95 | 4,349,880 | 60,463,400 | reduced | -3.26 | ||
| CADL | candel therapeutics inc | 2.57 | 2,896,590 | 14,193,300 | new | |||
| CELC | celcuity inc | 5.83 | 281,904 | 32,176,500 | reduced | -11.1 | ||
| CNTA | centessa pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| COGT | cogent biosciences inc | 4.37 | 626,635 | 24,119,200 | reduced | -48.51 | ||
| DYN | dyne therapeutics inc | 3.17 | 966,609 | 17,524,600 | reduced | -45.96 | ||
| IKT | inhibikase therapeutics inc | 1.18 | 3,863,440 | 6,490,590 | added | 0.17 | ||
| IMMX | immix biopharma inc | 6.09 | 3,693,580 | 33,648,600 | added | 23.15 | ||
| IVA | inventiva sa | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| JAZZ | jazz pharmaceuticals plc | 5.58 | 162,961 | 30,807,800 | reduced | -34.31 | ||
| MNPR | monopar therapeutics inc | 3.43 | 345,626 | 18,936,800 | added | 6.12 | ||
| OCUL | ocular therapeutix inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| OVID | ovid therapeutics inc | 1.68 | 4,166,670 | 9,250,000 | added | 66.67 | ||
| PCVX | vaxcyte inc | 8.68 | 824,532 | 47,913,600 | added | 3.2 | ||
| PHVS | pharvaris n v | 6.15 | 1,201,400 | 33,939,600 | added | 5.38 | ||
| XFOR | x4 pharmaceuticals inc | 4.83 | 6,456,650 | 26,665,900 | added | 11.31 | ||
| alumis inc | 12.77 | 3,202,080 | 70,541,700 | added | 2.11 | |||
| abivax sa | 10.94 | 542,696 | 60,429,200 | reduced | -16.4 | |||
| disc medicine inc | 5.21 | 449,926 | 28,768,300 | added | 50.76 | |||